[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334134-105":59,"doc-detail-334134-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","minimally-invasive-and-emerging-diagnostic-approaches-in-endometrial-cancer-epigenetic-insights-and-the-promise-of-dna-methylation","Minimally Invasive and Emerging Diagnostic Approaches in Endometrial Cancer - Epigenetic Insights and the Promise of DNA Methylation","","Endometrial cancer (EC) is the most common gynecological malignancy, with rising incidence and mortality. Key risk factors such as obesity, prolonged estrogen exposure, and metabolic disorders drive demand for effective, non-invasive early diagnostic tools. This review examines DNA methylation as an epigenetic biomarker for early EC detection, focusing on aberrant promoter-region methylation and minimally invasive sample strategies. Reported markers show high diagnostic accuracy, with AUC values up to 0.95, enabling improved detection timing, risk stratification, and personalized management.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/minimally-invasive-and-emerging-diagnostic-approaches-in-endometrial-cancer-epigenetic-insights-and-the-promise-of-dna-methylation/334134/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/minimally-invasive-and-emerging-diagnostic-approaches-in-endometrial-cancer-epigenetic-insights-and-the-promise-of-dna-methylation/334134.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is early diagnosis of endometrial cancer urgently needed?","Question",{"text":112,"@type":113},"Rising incidence and mortality, along with future projections, indicate a growing public health burden. Early detection improves prognosis and supports more effective management.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does DNA methylation contribute to endometrial cancer diagnosis?",{"text":117,"@type":113},"Aberrant DNA methylation in promoter regions of tumor suppressor genes can lead to gene silencing and cancer progression. DNA methylation patterns can be detected to distinguish EC from non-cancerous conditions.",{"name":119,"@type":110,"acceptedAnswer":120},"Which minimally invasive samples are discussed for DNA methylation testing?",{"text":121,"@type":113},"The review highlights minimally invasive samples including urine, cervicovaginal, and cervical scrapes. These enable detection of early-stage EC through methylation marker patterns.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334134,1790174517,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Review  \nMinimally Invasive and Emerging Diagnostic Approaches in Endometrial Cancer: Epigenetic Insights and the Promise of DNA Methylation  \nFloriana Porcaro 1, Antonella Paolucci 2, Piercarmine Porcaro 1, Gaetano Cardinale 3, Antonia Romitelli 4, Domenico Cozzolino 3 and Serena Voccola 5, *  \nCitation: Porcaro, F.; Paolucci, A.; Porcaro, P.; Cardinale, G.; Romitelli, A.; Cozzolino, D.; Voccola, S. Minimally Invasive and Emerging Diagnostic Approaches in Endometrial Cancer: Epigenetic Insights and the Promise of DNA Methylation. Diagnostics 2024, 14, 2575. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)diagnostics14222575  \nAcademic Editor: Cinzia Giacometti  \nReceived: 4 October 2024  \nRevised: 8 November 2024  \nAccepted: 14 November 2024  \nPublished: 15 November 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Centro Medico Delta S.r.l., 82030 Apollosa, Italy; [floriana.porcaro@gmail.com](floriana.porcaro@gmail.com) (F.P.); [piercarmine.porcaro1@gmail.com](piercarmine.porcaro1@gmail.com) (P.P.)  \n2 Centro Prevenzione Donna, 05100 Terni, Italy; [antonellapao@icloud.com](antonellapao@icloud.com)  \n3 Tecno Bios S.r.l., 82030 Apollosa, Italy; [gaetano.cardinale@tecnobios.com](gaetano.cardinale@tecnobios.com) (G.C.); [domenico.cozzolino@tecnobios.com](domenico.cozzolino@tecnobios.com) (D.C.)  \n4 Delta Biotech S.r.l., 82030 Apollosa, Italy; antonia.romitelli@deltabiotech.it  \n5 Consorzio Sannio Tech, 82030 Apollosa, Italy  \n* Correspondence: [serenavoccola@gmail.com](serenavoccola@gmail.com)  \nAbstract: Endometrial cancer (EC) is the most common gynecological malignancy, with rising incidence and mortality rates. Key risk factors, including obesity, prolonged estrogen exposure, and metabolic disorders, underscore the urgent need for non-invasive, early diagnostic tools. This review focuses on the role of DNA methylation as a potential biomarker for early EC detection. Aberrant DNA methylation in the promoter regions of tumor suppressor genes can lead to gene silencing and cancer progression. We examine recent studies utilizing minimally invasive samples, such as urine, cervicovaginal, and cervical scrapes, to detect early-stage EC through DNA methylation patterns. Markers such as RASSF1A, HIST1H4F, GHSR, SST, and ZIC1 have demonstrated high diagnostic accuracy, with AUC values up to 0.95, effectively distinguishing EC from non-cancerous conditions. This review highlights the potential of DNA methylation-based testing as a non-invasive alternative to traditional diagnostic methods, offering earlier detection, better risk stratification, and more personalized treatment plans. These innovations hold the promise of transforming clinical practice by enabling more timely and effective management of endometrial cancer.  \nKeywords: endometrial cancer; DNA methylation; epigenetic biomarkers; non-invasive diagnostics; obesity-related cancer risk; early cancer detection  \n1. Introduction  \nEpidemiology and Risk Factors of Endometrial Carcinoma  \nEndometrial cancer (EC) is a malignancy of the inner epithelial lining of the uterus. It is the most prevalent gynecological malignancy, with global incidence and mortality rateson the rise [1] . Most women are between 65 and 75 years old when they are diagnosed with endometrial cancer [2] . The increasing incidence of endometrial cancer represents a significant concern for public health, especially in developed countries. Recent studies have projected a considerable rise in the incidence of this cancer in the coming decades. Specifically, the best-fitting model projected an increase to 42.13 endometrial cancer cases per 100,000 by the year 2030, a 55","cbCaifXBfDLSVUZf","https://ap.wps.com/l/cbCaifXBfDLSVUZf","pdf",770720,13,"English","# Introduction\n## Epidemiology and Risk Factors of Endometrial Carcinoma\n# Abstract\n# Keywords","[{\"question\":\"Why is early diagnosis of endometrial cancer urgently needed?\",\"answer\":\"Rising incidence and mortality, along with future projections, indicate a growing public health burden. Early detection improves prognosis and supports more effective management.\"},{\"question\":\"How does DNA methylation contribute to endometrial cancer diagnosis?\",\"answer\":\"Aberrant DNA methylation in promoter regions of tumor suppressor genes can lead to gene silencing and cancer progression. DNA methylation patterns can be detected to distinguish EC from non-cancerous conditions.\"},{\"question\":\"Which minimally invasive samples are discussed for DNA methylation testing?\",\"answer\":\"The review highlights minimally invasive samples including urine, cervicovaginal, and cervical scrapes. These enable detection of early-stage EC through methylation marker patterns.\"}]","Minimally Invasive and Emerging Diagnostic Approaches in Endometrial Cancer - Epigenetic Insights and the Promise of DNA Methylation | PDF",1790005456,33]